The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Analyses of Smad2 (pS465/pS467)/Smad3 (pS423/pS425) expression.
Panel 1: Flow cytometric analysis of Ramos cells, human PBMC, and mouse spleen cells. Cells were cultured overnight in serum-free medium (Ramos, spleen) or medium containing 0.1% FBS (PBMC) and then either not treated (dashed line histogram) or treated with TGF-β (solid line histogram; Cat. No. 354039; 10 ng/mL, 30 min, 37°C). Cells were fixed in 1X BD Phosflow™ Lyse/Fix Buffer (Cat. No. 558049; 10 min, 37°C) and permeabilized in BD Phosflow™ Perm Buffer III (Cat. No. 558050; 30 min, on ice). Cells were stained with BD Phosflow™ PE-CF594 Mouse Anti-Smad2 (pS465/pS467)/Smad3 (pS423/pS425) antibody (Cat. No. 562697). PBMC were co-stained with PerCP-Cy™5.5 Mouse Anti-Human CD20 antibody (Cat. No. 558021). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of intact cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Panel 2: Western blot analyses. Cells were serum-starved overnight and then either not treated (C) or treated with TGF-β (T), as in Panel 1. Lysates were blotted using Purified Mouse Anti-Smad2 (pS465/pS467)/Smad3 (pS423/pS425) antibody (Clone O72-670; 2 µg/mL). Phosphorylated Smad2 and Smad3 were identified as ~60 kDa and ~52 kDa bands, respectively. The lower molecular weight band detected in mouse spleen lysates is endogenous mouse Ig light chain.
Panel 3: Immunohistochemical staining. An EDTA-pretreated, formalin-fixed, paraffin-embedded human tonsil section was stained with Ig Isotype Control (Cat. No. 550878) or Purified Mouse Anti-Smad2 (pS465/pS467)/Smad3 (pS423/pS425) antibody (Clone O72-670; 20X original magnification).
Analyses of Smad2 (pS465/pS467)/Smad3 (pS423/pS425) expression.
Panel 1: Flow cytometric analysis of Ramos cells, human PBMC, and mouse spleen cells. Cells were cultured overnight in serum-free medium (Ramos, spleen) or medium containing 0.1% FBS (PBMC) and then either not treated (dashed line histogram) or treated with TGF-β (solid line histogram; Cat. No. 354039; 10 ng/mL, 30 min, 37°C). Cells were fixed in 1X BD Phosflow™ Lyse/Fix Buffer (Cat. No. 558049; 10 min, 37°C) and permeabilized in BD Phosflow™ Perm Buffer III (Cat. No. 558050; 30 min, on ice). Cells were stained with BD Phosflow™ PE-CF594 Mouse Anti-Smad2 (pS465/pS467)/Smad3 (pS423/pS425) antibody (Cat. No. 562697). PBMC were co-stained with PerCP-Cy™5.5 Mouse Anti-Human CD20 antibody (Cat. No. 558021). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of intact cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Panel 2: Western blot analyses. Cells were serum-starved overnight and then either not treated (C) or treated with TGF-β (T), as in Panel 1. Lysates were blotted using Purified Mouse Anti-Smad2 (pS465/pS467)/Smad3 (pS423/pS425) antibody (Clone O72-670; 2 µg/mL). Phosphorylated Smad2 and Smad3 were identified as ~60 kDa and ~52 kDa bands, respectively. The lower molecular weight band detected in mouse spleen lysates is endogenous mouse Ig light chain.
Panel 3: Immunohistochemical staining. An EDTA-pretreated, formalin-fixed, paraffin-embedded human tonsil section was stained with Ig Isotype Control (Cat. No. 550878) or Purified Mouse Anti-Smad2 (pS465/pS467)/Smad3 (pS423/pS425) antibody (Clone O72-670; 20X original magnification).
Analyses of Smad2 (pS465/pS467)/Smad3 (pS423/pS425) expression.
Panel 1: Flow cytometric analysis of Ramos cells, human PBMC, and mouse spleen cells. Cells were cultured overnight in serum-free medium (Ramos, spleen) or medium containing 0.1% FBS (PBMC) and then either not treated (dashed line histogram) or treated with TGF-β (solid line histogram; Cat. No. 354039; 10 ng/mL, 30 min, 37°C). Cells were fixed in 1X BD Phosflow™ Lyse/Fix Buffer (Cat. No. 558049; 10 min, 37°C) and permeabilized in BD Phosflow™ Perm Buffer III (Cat. No. 558050; 30 min, on ice). Cells were stained with BD Phosflow™ PE-CF594 Mouse Anti-Smad2 (pS465/pS467)/Smad3 (pS423/pS425) antibody (Cat. No. 562697). PBMC were co-stained with PerCP-Cy™5.5 Mouse Anti-Human CD20 antibody (Cat. No. 558021). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of intact cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Panel 2: Western blot analyses. Cells were serum-starved overnight and then either not treated (C) or treated with TGF-β (T), as in Panel 1. Lysates were blotted using Purified Mouse Anti-Smad2 (pS465/pS467)/Smad3 (pS423/pS425) antibody (Clone O72-670; 2 µg/mL). Phosphorylated Smad2 and Smad3 were identified as ~60 kDa and ~52 kDa bands, respectively. The lower molecular weight band detected in mouse spleen lysates is endogenous mouse Ig light chain.
Panel 3: Immunohistochemical staining. An EDTA-pretreated, formalin-fixed, paraffin-embedded human tonsil section was stained with Ig Isotype Control (Cat. No. 550878) or Purified Mouse Anti-Smad2 (pS465/pS467)/Smad3 (pS423/pS425) antibody (Clone O72-670; 20X original magnification).
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
This fluorescent antibody is suitable for intracellular staining of human lymphoid cell lines, peripheral blood mononuclear cells, and mouse splenocytes using BD Cytofix™ Fixation Buffer or BD Phosflow™ Lyse/Fix Buffer with BD Phosflow™ Perm Buffer III (see table, below). Prior to stimulation, cells were serum starved overnight at a density of 2-10X10^6 cells/mL in flat-bottom 96- or 6-well tissue culture plates or in loosely capped, round-bottom tubes containing approximately 100 mL of cells in suspension.
Note:
1. Serum starvation for 2 hours following PBMC isolation was not sufficient to reduce basal phosphorylation of Smad2 and Smad3.
2. Do not mix or agitate untreated cells until just before the cells are ready to be fixed, since agitation of serum-starved mouse or human primary leukocytes prior to fixation increased Smad2/3 phosphorylation, even in the absence of exogenous TGF-β
The O72-670 monoclonal antibody specifically binds to the Smad2 protein phosphorylated at the Ser465/467 sites and the Smad3 protein phosphorylated at the Ser423/425 sites. Smad2 and Smad3 are members of the Smad superfamily with observed molecular weights of 60 kDa and 52 kDa, respectively. The Smad family consists of three subfamilies: receptor regulated Smads or R-Smads, including Smads1, 2, 3, 5, and 8; common partner Smad, or Co-Smad, including Smad4; and inhibitory Smads, or I-Smad, including Smads 6 and 7. Activation of TGF-beta superfamily serine/threonine kinase receptors, such as TGF-beta, activin and BMP receptors, by their bound ligands leads to the phosphorylation of R-Smads at several sites. It has been shown that the ligand-bound TGF-beta type I receptor directly phosphorylates Ser465 and Ser467 of Smad2 and Ser423 and Ser425 of Smad3. Phosphorylated R-Smads form complexes with Co-Smad and translocate into the nucleus to regulate transcription affecting a wide range of critical cellular processes including cell-fate determination, proliferation, morphogenesis, differentiation and apoptosis. The inhibitory Smads inhibit this pathway through two potential mechanisms: either by preventing R-Smads from binding to their corresponding receptors and/or by competing with Smad4, the Co-Smad, from binding to R-Smads. High level expression of phosphorylated Smad2 has been associated with poor prognosis in late stage gastric carcinoma. Roles for Smad2 have been described in thymopoiesis and the TGF-β-mediated induction of regulatory T cells and Th17 cells. The specificity of the O72-670 mAb was confirmed by Western blot and immunohistochemistry using unconjugated antibody.
This antibody is conjugated to BD Horizon™ PE-CF594, which has been developed exclusively by BD Biosciences as a better alternative to PE-Texas Red®. PE-CF594 excites and emits at similar wavelengths to PE-Texas Red® yet exhibits improved brightness and spectral characteristics. Due to PE having maximal absorption peaks at 496 nm and 564 nm, PE-CF594 can be excited by the blue (488-nm), green (532-nm) and yellow-green (561-nm) lasers and can be detected with the same filter set as PE-Texas Red® (eg 610/20-nm filter).
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.